메뉴 건너뛰기




Volumn 75, Issue 2, 2005, Pages 195-201

Changes in the Vif protein of HIV-1 associated with the development of resistance to inhibitors of viral protease

Author keywords

HIV 1; Protease inhibitor resistance; Vif

Indexed keywords

PROTEINASE; VIF PROTEIN;

EID: 11144248344     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmv.20256     Document Type: Article
Times cited : (6)

References (32)
  • 1
    • 0034771945 scopus 로고    scopus 로고
    • Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: Co-encapsidation and interference with viral protease-mediated Gag processing
    • Bardy M, Gay B, Pebernard S, Chazal N, Courcoul M, Vigne R, Decroly E, Boulanger P. 2001. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: Co-encapsidation and interference with viral protease-mediated Gag processing. J Gen Virol 82:2719-2733.
    • (2001) J Gen Virol , vol.82 , pp. 2719-2733
    • Bardy, M.1    Gay, B.2    Pebernard, S.3    Chazal, N.4    Courcoul, M.5    Vigne, R.6    Decroly, E.7    Boulanger, P.8
  • 2
    • 0031724008 scopus 로고    scopus 로고
    • Resistance to human immunodeficiency virus type 1 protease inhibitors
    • Boden D, Markowitz M. 1998. Resistance to human immunodeficiency virus type 1 protease inhibitors. Antimicrob Agents Chemother 42:2775-2783.
    • (1998) Antimicrob Agents Chemother , vol.42 , pp. 2775-2783
    • Boden, D.1    Markowitz, M.2
  • 3
    • 0028915063 scopus 로고
    • Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity
    • Borman AM, Quillent C, Charneau P, Dauguet C, Clavel F. 1995. Human immunodeficiency virus type 1 Vif-mutant particles from restrictive cells: Role of Vif in correct particle assembly and infectivity. J Virol 69:2058-2067.
    • (1995) J Virol , vol.69 , pp. 2058-2067
    • Borman, A.M.1    Quillent, C.2    Charneau, P.3    Dauguet, C.4    Clavel, F.5
  • 6
    • 0031015475 scopus 로고    scopus 로고
    • Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors
    • Croteau G, Doyon L, Thibeault D, McKercher G, Pilote L, Lamarre D. 1997. Impaired fitness of human immunodeficiency virus type 1 variants with high-level resistance to protease inhibitors. J Virol 71:1089-1096.
    • (1997) J Virol , vol.71 , pp. 1089-1096
    • Croteau, G.1    Doyon, L.2    Thibeault, D.3    McKercher, G.4    Pilote, L.5    Lamarre, D.6
  • 9
    • 0026070511 scopus 로고
    • A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein
    • Guy B, Geist M, Dott K, Spehner D, Kieny MP, Lecocq JP. 1991. A specific inhibitor of cysteine proteases impairs a Vif-dependent modification of human immunodeficiency virus type 1 Env protein. J Virol 65:1325-1331.
    • (1991) J Virol , vol.65 , pp. 1325-1331
    • Guy, B.1    Geist, M.2    Dott, K.3    Spehner, D.4    Kieny, M.P.5    Lecocq, J.P.6
  • 12
    • 0028200823 scopus 로고
    • Role of vif during packing of the core of HIV-1
    • Hoglund S, Ohagen A, Lawrence K, Gabuzda D. 1994. Role of vif during packing of the core of HIV-1. Virology 201:349-355.
    • (1994) Virology , vol.201 , pp. 349-355
    • Hoglund, S.1    Ohagen, A.2    Lawrence, K.3    Gabuzda, D.4
  • 15
    • 0038363470 scopus 로고    scopus 로고
    • Hypermutation of HIV-1 DNA in the absence of the Vif protein
    • Lecossier D, Bouchonnet F, Clavel F, Hance AJ. 2003. Hypermutation of HIV-1 DNA in the absence of the Vif protein. Science 300:1112.
    • (2003) Science , vol.300 , pp. 1112
    • Lecossier, D.1    Bouchonnet, F.2    Clavel, F.3    Hance, A.J.4
  • 16
    • 0027980114 scopus 로고
    • Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity
    • Ma XY, Sova P, Chao W, Volsky DJ. 1994. Cysteine residues in the Vif protein of human immunodeficiency virus type 1 are essential for viral infectivity. J Virol 68:1714-1720.
    • (1994) J Virol , vol.68 , pp. 1714-1720
    • Ma, X.Y.1    Sova, P.2    Chao, W.3    Volsky, D.J.4
  • 17
    • 0031797865 scopus 로고    scopus 로고
    • An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein
    • Madani N, Kabat D. 1998. An endogenous inhibitor of human immunodeficiency virus in human lymphocytes is overcome by the viral Vif protein. J Virol 72:10251-10255.
    • (1998) J Virol , vol.72 , pp. 10251-10255
    • Madani, N.1    Kabat, D.2
  • 18
    • 0038681023 scopus 로고    scopus 로고
    • Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts
    • Mangeat B, Turelli P, Caron G, Friedli M, Perrin L, Trono D. 2003. Broad antiretroviral defence by human APOBEC3G through lethal editing of nascent reverse transcripts. Nature 424:99-103.
    • (2003) Nature , vol.424 , pp. 99-103
    • Mangeat, B.1    Turelli, P.2    Caron, G.3    Friedli, M.4    Perrin, L.5    Trono, D.6
  • 19
    • 0344845196 scopus 로고    scopus 로고
    • HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation
    • Marin M, Rose KM, Kozak SL, Kabat D. 2003. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation. Nat Med 9:1398-1403.
    • (2003) Nat Med , vol.9 , pp. 1398-1403
    • Marin, M.1    Rose, K.M.2    Kozak, S.L.3    Kabat, D.4
  • 21
    • 0027447213 scopus 로고
    • Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles
    • Sakai H, Shibata R, Sakuragi J, Sakuragi S, Kawamura M, Adachi A. 1993. Cell-dependent requirement of human immunodeficiency virus type 1 Vif protein for maturation of virus particles. J Virol 67:1663-1666.
    • (1993) J Virol , vol.67 , pp. 1663-1666
    • Sakai, H.1    Shibata, R.2    Sakuragi, J.3    Sakuragi, S.4    Kawamura, M.5    Adachi, A.6
  • 22
    • 0037043699 scopus 로고    scopus 로고
    • Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein
    • Sheehy AM, Gaddis NC, Choi JD, Malim MH. 2002. Isolation of a human gene that inhibits HIV-1 infection and is suppressed by the viral Vif protein. Nature 418:646-650.
    • (2002) Nature , vol.418 , pp. 646-650
    • Sheehy, A.M.1    Gaddis, N.C.2    Choi, J.D.3    Malim, M.H.4
  • 23
    • 0344413641 scopus 로고    scopus 로고
    • The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif
    • Sheehy AM, Gaddis NC, Malim MH. 2003. The antiretroviral enzyme APOBEC3G is degraded by the proteasome in response to HIV-1 Vif. Nat Med 9:1404-1407.
    • (2003) Nat Med , vol.9 , pp. 1404-1407
    • Sheehy, A.M.1    Gaddis, N.C.2    Malim, M.H.3
  • 24
    • 0029056704 scopus 로고
    • Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes
    • Simm M, Shahabuddin M, Chao W, Allan JS, Volsky DJ. 1995. Aberrant Gag protein composition of a human immunodeficiency virus type 1 vif mutant produced in primary lymphocytes. J Virol 69 :4582-4586.
    • (1995) J Virol , vol.69 , pp. 4582-4586
    • Simm, M.1    Shahabuddin, M.2    Chao, W.3    Allan, J.S.4    Volsky, D.J.5
  • 25
    • 0029956256 scopus 로고    scopus 로고
    • The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes
    • Simon JH, Malim MH. 1996. The human immunodeficiency virus type 1 Vif protein modulates the postpenetration stability of viral nucleoprotein complexes. J Virol 70:5297-5305.
    • (1996) J Virol , vol.70 , pp. 5297-5305
    • Simon, J.H.1    Malim, M.H.2
  • 26
    • 0031788565 scopus 로고    scopus 로고
    • Evidence for a newly discovered cellular anti-HIV-1 phenotype
    • Simon JH, Gaddis NC, Fouchier RA, Malim MH. 1998. Evidence for a newly discovered cellular anti-HIV-1 phenotype. Nat Med 4:1397-1400.
    • (1998) Nat Med , vol.4 , pp. 1397-1400
    • Simon, J.H.1    Gaddis, N.C.2    Fouchier, R.A.3    Malim, M.H.4
  • 27
    • 0033053198 scopus 로고    scopus 로고
    • Mutational analysis of the human immunodeficiency virus type 1 Vif protein
    • Simon JH, Sheehy AM, Carpenter EA, Fouchier RA, Malim MH. 1999. Mutational analysis of the human immunodeficiency virus type 1 Vif protein. J Virol 73:2675-2681.
    • (1999) J Virol , vol.73 , pp. 2675-2681
    • Simon, J.H.1    Sheehy, A.M.2    Carpenter, E.A.3    Fouchier, R.A.4    Malim, M.H.5
  • 28
    • 0141638436 scopus 로고    scopus 로고
    • HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability
    • Stopak K, de Noronha C, Yonemoto W, Greene WC. 2003. HIV-1 Vif blocks the antiviral activity of APOBEC3G by impairing both its translation and intracellular stability. Mol Cell 12:591-601.
    • (2003) Mol Cell , vol.12 , pp. 591-601
    • Stopak, K.1    De Noronha, C.2    Yonemoto, W.3    Greene, W.C.4
  • 31
    • 0030769354 scopus 로고    scopus 로고
    • Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites
    • Zhang YM, Imamichi H, Imamichi T, Lane HC, Falloon J, Vasudevachari MB, Salzman NP. 1997. Drug resistance during indinavir therapy is caused by mutations in the protease gene and in its Gag substrate cleavage sites. J Virol 71:6662-6670.
    • (1997) J Virol , vol.71 , pp. 6662-6670
    • Zhang, Y.M.1    Imamichi, H.2    Imamichi, T.3    Lane, H.C.4    Falloon, J.5    Vasudevachari, M.B.6    Salzman, N.P.7
  • 32
    • 0038004471 scopus 로고    scopus 로고
    • The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA
    • Zhang H, Yang B, Pomerantz RJ, Zhang CM, Arunachalam SC, Gao L. 2003. The cytidine deaminase CEM15 induces hypermutation in newly synthesized HIV-1 DNA. Nature 424:94-98.
    • (2003) Nature , vol.424 , pp. 94-98
    • Zhang, H.1    Yang, B.2    Pomerantz, R.J.3    Zhang, C.M.4    Arunachalam, S.C.5    Gao, L.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.